Last reviewed · How we verify

Stepwise add-on therapy

Korea University Anam Hospital · Phase 3 active Small molecule

Stepwise add-on therapy is a treatment strategy that sequentially adds medications to achieve therapeutic goals rather than using a single high-dose agent.

At a glance

Generic nameStepwise add-on therapy
Also known asMetformin, Glimepiride, Sitagliptin
SponsorKorea University Anam Hospital
ModalitySmall molecule
PhasePhase 3

Mechanism of action

This approach involves initiating treatment with a single agent at a standard dose, then progressively adding complementary medications based on clinical response and tolerability. The stepwise strategy aims to optimize efficacy while minimizing adverse effects by titrating therapy incrementally rather than starting with combination regimens.

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: